CSF & Blood-Brain Barrier
CSF & Blood-Brain Barrier
What You'll Learn
- CSF production & circulation — choroid plexus (70%), total volume ~150 mL, production ~500 mL/day, turned over 3–4×/day; flow: lateral ventricles → foramen of Monro → 3rd ventricle → aqueduct of Sylvius → 4th ventricle → Luschka/Magendie → subarachnoid space → arachnoid granulations → superior sagittal sinus
- Normal CSF values — opening pressure 6–20 cmH2O (up to 25 may be normal in some adults), protein 15–45 mg/dL, glucose 50–80 mg/dL, ~⅔ (60–70%) of serum glucose, WBC <5 lymphocytes, RBC 0, clear & colorless
- CSF in disease — bacterial (PMNs, ↓↓glucose, ↑↑protein), viral (lymphocytes, normal glucose), TB/fungal (lymphocytes, ↓glucose), GBS (albuminocytologic dissociation, may be absent in week 1), MS (CSF-unique oligoclonal bands, ↑IgG index), SAH (RBCs + xanthochromia after ~6–12 h; no universally accepted RBC cutoff — serial-tube clearing only suggestive, not definitive)
- Hydrocephalus — communicating vs obstructive; NPH triad (wet–wacky–wobbly); pseudotumor cerebri/IIH (young obese women, papilledema, empty sella)
- Blood-brain barrier — physical paracellular barrier = cerebral endothelial tight junctions, supported by basement membrane, pericytes, and astrocyte endfeet (astrocytic AQP4 supports water handling + NMOSD antigen biology, but is NOT the primary paracellular barrier); lipophilic/small/uncharged molecules cross; circumventricular organs LACK BBB (area postrema, median eminence, neurohypophysis, pineal, subfornical organ, OVLT)
- BBB disruption — infection, tumors, ischemia → contrast enhancement on MRI = BBB breakdown
- Lumbar puncture — contraindications (mass with midline shift, coagulopathy), complications (post-LP headache, herniation)
HighYield Pearls
- CSF production ~500 mL/day, ~20 mL/hr, total volume ~150 mL: turned over 3–4×/day; choroid plexus is the dominant source; actively secreted, NOT ultrafiltered — acetazolamide ↓ production via carbonic anhydrase inhibition (basis for IIH treatment).
- Flow path — lateral → Monro → 3rd → aqueduct of Sylvius → 4th → Luschka (Lateral) + Magendie (Midline) → subarachnoid space → arachnoid granulations → superior sagittal sinus: aqueduct of Sylvius is the narrowest point and most common site of obstructive hydrocephalus.
- Normal CSF values: opening pressure 6–20 cmH2O (lateral decubitus, legs extended; >25 abnormal), WBC ≤5 lymphocytes, protein 15–45 mg/dL, glucose >50 OR ≥0.6 of serum, clear & colorless.
- Bacterial meningitis CSF: WBC >1000 PMN-predominant, glucose <40 (or <0.4 of serum), protein >200, Gram stain + culture — LOW glucose distinguishes bacterial/TB/fungal from viral.
- Viral meningoencephalitis CSF: WBC <500 lymphocyte-predominant, NORMAL glucose, mildly elevated protein — HSV PCR is the test for HSE; do NOT wait for it to start acyclovir.
- TB & cryptococcal meningitis: lymphocytic + LOW glucose + HIGH protein; TB needs AFB/PCR/culture; cryptococcal needs India ink + CrAg (sensitive).
- MS CSF: ≥2 oligoclonal bands unique to CSF (not serum) + elevated IgG index + kappa free light chains; AQP4-IgG for NMOSD, MOG-IgG for MOGAD — check serum, not just CSF.
- GBS CSF: albuminocytologic dissociation (HIGH protein with NORMAL cell count) is typical but may be absent early — CSF protein is normal in ~50% during week 1 and more often elevated by week 2. Normal early CSF does NOT rule out GBS; pleocytosis should prompt reconsideration / alternative diagnosis (also seen in CIDP).
- SAH (LP after negative/indeterminate CT): evaluate RBCs plus xanthochromia. Xanthochromia after ~6–12 h supports true SAH; serial-tube RBC clearing (tube 1→4) can suggest traumatic tap but is not definitive (SAH and traumatic tap can coexist). No universally accepted single RBC cutoff — don't use one RBC number as a stand-alone rule.
- BBB anatomy — endothelial TIGHT JUNCTIONS are the barrier (NOT astrocyte foot processes — those provide trophic support + induce TJs); + P-glycoprotein efflux, GLUT1 + LAT1 transporters; circumventricular organs LACK BBB (area postrema, median eminence, OVLT, SFO, pineal, neurohypophysis).
- Glymphatic system: peri-arterial CSF influx → AQP4-dependent astrocytic exchange → peri-venous drainage to meningeal lymphatics; clears amyloid + tau; most active during sleep; impaired in AD, post-trauma, sleep deprivation.
- Post-LP headache: orthostatic from CSF leak; prevent with 22–25 G atraumatic (pencil-point) needles; treat with epidural blood patch, supine, caffeine, hydration.
🔍 Quick ReferenceCSF physiology · BBB / glymphatic · Disease CSF patterns
CSF production / flow
- Choroid plexus epithelium (Na/K-ATPase + carbonic anhydrase) → active CSF secretion ~500 mL/day; acetazolamide & topiramate inhibit CA → ↓ production (IIH)
- Aqueduct of Sylvius → narrowest segment & most common site of obstructive hydrocephalus (congenital X-linked L1CAM, tectal glioma)
- Luschka (Lateral) + Magendie (Midline) → 4th ventricle outflow into subarachnoid space
- Arachnoid granulations / villi → bulk CSF absorption into superior sagittal sinus (pressure-dependent)
- Cribriform plate + cranial nerve sheaths + meningeal lymphatics → alternative CSF efflux to cervical lymphatics
- Opening pressure >25 cmH2O (lateral decubitus, legs extended) → IIH, mass effect, hydrocephalus, CVT, meningitis
- Endothelial tight junctions + P-glycoprotein efflux + GLUT1 + LAT1 → true BBB — excludes large/polar molecules & most antibiotics
- Astrocytic end-foot processes + AQP4 channels → induce + maintain TJs; AQP4 is NMOSD antigen
- Circumventricular organs (area postrema, median eminence, OVLT, SFO, pineal, neurohypophysis) → NO BBB by design — sense peripheral signals (area postrema = chemoreceptor trigger zone for vomiting)
- Choroid plexus (blood-CSF barrier) → tight junctions between epithelial cells (capillaries are fenestrated)
- Perineurium + endoneurial capillaries (blood-nerve barrier) → less robust than BBB — explains paraprotein/GBS PNS targeting
- Glymphatic peri-arterial influx → AQP4 astrocytic exchange → peri-venous efflux → meningeal lymphatics → clears amyloid + tau + lactate; sleep-active; impaired in AD/CTE/sleep deprivation
- Contrast enhancement on MRI → BBB breakdown (tumor, infection, demyelination, infarct)
- WBC >1000 PMN + glucose <40 + protein >200 + Gram stain → bacterial meningitis
- Lymphocytic pleocytosis <500 + NORMAL glucose + mildly ↑ protein + HSV PCR → viral meningoencephalitis (HSE: temporal lobe involvement)
- Lymphocytic + LOW glucose + HIGH protein + AFB/PCR → TB meningitis (basilar enhancement, hydrocephalus)
- Lymphocytic + low glucose + India ink + cryptococcal antigen (CrAg) → cryptococcal meningitis (HIV/immunosuppressed)
- ≥2 oligoclonal bands unique to CSF + ↑ IgG index + ↑ kappa free light chains → multiple sclerosis
- Albuminocytologic dissociation (↑ protein, normal cells) — typical but may be absent early; CSF protein normal in ~50% during week 1, more often elevated by week 2; normal early CSF does NOT rule out GBS; pleocytosis → reconsider/alternative dx → GBS / CIDP
- RBCs + xanthochromia after ~6–12 h + ↑ opening pressure → subarachnoid hemorrhage (serial-tube clearing only suggestive of traumatic tap; no universally accepted single RBC cutoff)
- 14-3-3 + tau + RT-QuIC positive → Creutzfeldt-Jakob disease
- Large atypical lymphocytes on cytology + flow cytometry → primary CNS lymphoma (PCNSL)
- Lymphocytic + OCBs + paraneoplastic/AIE antibody panel (NMDAR, LGI1, CASPR2, GAD65) → autoimmune / paraneoplastic encephalitis
BBB / glymphatic
Disease CSF patterns
CSF Production
Sources & Basic Parameters
- Choroid plexus — produces the majority (~60–70%) of CSF; located in lateral, 3rd, and 4th ventricles (most in lateral ventricles)
- Ependymal lining / brain interstitium — contributes the remainder (~30–40%)
- Total CSF volume: ~150 mL (adults)
- Production rate: ~20 mL/hr (~500 mL/day)
- Turnover: entire volume replaced 3–4×/day
- Mechanism: active secretion (NOT ultrafiltration) — Na+/K+ ATPase on apical membrane of choroid epithelium drives ion transport; carbonic anhydrase involved; acetazolamide ↓ CSF production by inhibiting carbonic anhydrase
Board Pearl
CSF is actively secreted, not passively filtered. Acetazolamide reduces CSF production by inhibiting carbonic anhydrase in the choroid plexus — this is the basis for its use in idiopathic intracranial hypertension (IIH).
Continue reading — sign in
The full note has more clinical pearls, tables, and board-focused tips. Free account, no fee.